Updates on Use of Genomic Testing in Patients with High-Risk, Clinically Localized Prostate Cancer - Episode 9

Exciting Emerging Data in Prostate Cancer

Stephen J. Freedland, MD, highlights emerging data to look out for that might address unmet needs in prostate cancer testing and treatment.

EP. 1: Staging, Grading, and Risk Stratification of Prostate Cancer
EP. 2: Treatment Options for High-Risk, Clinically Localized Prostate Cancer
EP. 3: Clinical Challenges Surrounding Treatment Decision-Making in Clinically Localized Prostate Cancer
EP. 4: The Potential for Overtreatment or Undertreatment of Prostate Cancer
EP. 5: Addressing Clinical Challenges of Prostate Cancer Management with the Use of Genomic Testing
EP. 6: Available Genomic Tests for Clinically Localized Prostate Cancer
EP. 7: Clinical Study Data in Prostate Cancer Genomic Testing
EP. 8: Clinical Implications of Using Genomic Testing Results in Prostate Cancer Risk-Stratification and Treatment Selection
Now Viewing
EP. 9: Exciting Emerging Data in Prostate Cancer

Related Content:

Updates on Use of Genomic Testing in Patients with High-Risk, Clinically Localized Prostate CancerProstate CancerUroView
Dr. Tang on EXTEND trial in oligometastatic prostate cancer
Study results point to a need for shared decision-making in prostate cancer
Darolutamide nears EU approval for mHSPC